![]() |
|
|
Vol. 289, Issue 2, 831-839, May 1999
Laboratory of Pharmacology and Toxicology, We investigated temporal differences in the protective action of three
types of Ca2+ channel blockers in myocardial ischemia,
focusing particularly on the blocking ability under depolarizing
conditions. The effects of diltiazem, verapamil, and nifedipine on
extracellular potassium concentration
([K+]e), acidosis, and level of metabolic
markers were examined during 30-min global ischemia and postischemic
left ventricular (LV) function in isolated guinea pig hearts. Diltiazem
and verapamil, but not nifedipine, inhibited the late phase (15-30
min) of [K+]e elevation, whereas all three
blockers delayed the onset of the early phase (0-8 min) of
[K+]e elevation. Diltiazem and verapamil
inhibited ischemic contracture and improved postischemic LV function to
a greater extent. These differences appeared to be linked to
preservation of ATP and creatine phosphate and delay of cessation of
anaerobic glycolytic activity. Maneuvers to preserve energy sources
during ischemia (decrease in external Ca2+
concentration or pacing at a lower frequency) attenuated the late phase of [K+]e elevation. Inhibition of
LV pressure was potentiated 12- and 8.2-fold by diltiazem and
verapamil, respectively, at 8.9 mM K+ as compared with 2.9 mM K+, whereas that by nifedipine was unchanged. These
results indicate that the differential cardioprotection of
Ca2+ channel blockers in the late period of ischemia
correlates with preservation of high-energy phosphates as a result of
different Ca2+ channel blocking abilities under high
[K+]e conditions.
0022-3565/99/2892-0831$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics